95 related articles for article (PubMed ID: 21229623)
1. Synopsis of new antiangiogenetic factors, mutation compensation agents, and monoclonal antibodies in target therapies of breast cancer.
Grammatikakis I; Zervoudis S; Kassanos D
J BUON; 2010; 15(4):639-46. PubMed ID: 21229623
[TBL] [Abstract][Full Text] [Related]
2. Conclusions: future strategies in the treatment of breast cancer.
Piccart MJ; Hortobagyi GN
Semin Oncol; 1997 Feb; 24(1 Suppl 3):S34-40. PubMed ID: 9071339
[TBL] [Abstract][Full Text] [Related]
3. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
4. [Gene therapy and ovarian cancer: update of clinical trials].
Collinet P; Lanvin D; Vereecque R; Quesnel B; Querleu D
J Gynecol Obstet Biol Reprod (Paris); 2000 Oct; 29(6):532-7. PubMed ID: 11084459
[TBL] [Abstract][Full Text] [Related]
5. Biological therapy of breast cancer: recent clinical applications.
Baar J
Curr Opin Investig Drugs; 2007 Dec; 8(12):987-95. PubMed ID: 18058569
[TBL] [Abstract][Full Text] [Related]
6. Current immunotherapeutic strategies in breast cancer.
Carson WE; Liang MI
Surg Oncol Clin N Am; 2007 Oct; 16(4):841-60, ix. PubMed ID: 18022548
[TBL] [Abstract][Full Text] [Related]
7. [Biologic therapy and epithelial ovarian cancer].
Porpiglia M; Vicelli R; Durando A; Fracchioli S; Puopolo M; Katsaros D; Bellino R; Benedetto C
Minerva Ginecol; 2004 Feb; 56(1):91-104. PubMed ID: 14973413
[TBL] [Abstract][Full Text] [Related]
8. Progression and treatment of HER2-positive breast cancer.
Davoli A; Hocevar BA; Brown TL
Cancer Chemother Pharmacol; 2010 Mar; 65(4):611-23. PubMed ID: 20087739
[TBL] [Abstract][Full Text] [Related]
9. Triple-negative breast cancer.
Stockmans G; Deraedt K; Wildiers H; Moerman P; Paridaens R
Curr Opin Oncol; 2008 Nov; 20(6):614-20. PubMed ID: 18841042
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
Holmes FA
Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900
[TBL] [Abstract][Full Text] [Related]
11. Endocrine therapy and other targeted therapies for metastatic breast cancer.
Hussain SA; Palmer DH; Moon S; Rea DW
Expert Rev Anticancer Ther; 2004 Dec; 4(6):1179-95. PubMed ID: 15606341
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for carcinoma of the breast.
Stoff-Khalili MA; Dall P; Curiel DT
Cancer Gene Ther; 2006 Jul; 13(7):633-47. PubMed ID: 16410823
[TBL] [Abstract][Full Text] [Related]
13. Targeted immunotherapy for colorectal cancer: monoclonal antibodies and immunotoxins.
Shapira S; Lisiansky V; Arber N; Kraus S
Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S67-77. PubMed ID: 20374033
[TBL] [Abstract][Full Text] [Related]
14. Emerging targeted therapies for breast cancer.
Johnson ML; Seidman AD
Oncology (Williston Park); 2005 Apr; 19(5):611-8. PubMed ID: 15945342
[TBL] [Abstract][Full Text] [Related]
15. [Gene therapy of breast cancer].
Takeda Y; Tahara H
Nihon Rinsho; 2000 Apr; 58 Suppl():366-73. PubMed ID: 11026020
[No Abstract] [Full Text] [Related]
16. Novel Targeted Agents and Immunotherapy in Breast Cancer.
Mayer IA; Dent R; Tan T; Savas P; Loi S
Am Soc Clin Oncol Educ Book; 2017; 37():65-75. PubMed ID: 28561712
[TBL] [Abstract][Full Text] [Related]
17. Advances in Combining Radiation and Immunotherapy in Breast Cancer.
Nguyen AT; Shiao SL; McArthur HL
Clin Breast Cancer; 2021 Apr; 21(2):143-152. PubMed ID: 33810972
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy Leads to Complete Regression in Late-Stage Breast Cancer.
Abbasi J
JAMA; 2018 Jul; 320(2):127. PubMed ID: 29998319
[No Abstract] [Full Text] [Related]
19. Cancer therapy from bench to bedside.
Oh WK; Burakoff SJ
Mt Sinai J Med; 2010; 77(6):571-2. PubMed ID: 21105120
[No Abstract] [Full Text] [Related]
20. [Immunotherapy of breast cancer: identification of breast cancer antigens by SEREX].
Obata Y; Takahashi T; Iwase T; Iwata H; Murai H; Mizutani M; Miura S
Nihon Rinsho; 2000 Apr; 58 Suppl():357-65. PubMed ID: 11026019
[No Abstract] [Full Text] [Related]
[Next] [New Search]
